| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.
|
Pancreas
|
2010
|
3.00
|
|
2
|
Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis.
|
PLoS Genet
|
2006
|
2.62
|
|
3
|
Of mice and MEN1: Insulinomas in a conditional mouse knockout.
|
Mol Cell Biol
|
2003
|
2.12
|
|
4
|
Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.
|
J Clin Endocrinol Metab
|
2009
|
2.05
|
|
5
|
Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
|
Oncogene
|
2005
|
1.56
|
|
6
|
Localisation of mesenchymal tumours by somatostatin receptor imaging.
|
Lancet
|
2002
|
1.54
|
|
7
|
Reoperation for parathyroid adenoma: a contemporary experience.
|
Surgery
|
2009
|
1.50
|
|
8
|
The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene.
|
Mol Cell Biol
|
2003
|
1.48
|
|
9
|
Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds.
|
Medicine (Baltimore)
|
2002
|
1.25
|
|
10
|
Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism.
|
Cancer Res
|
2003
|
1.22
|
|
11
|
Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter.
|
Proc Natl Acad Sci U S A
|
2003
|
1.21
|
|
12
|
Molecular pathology of the MEN1 gene.
|
Ann N Y Acad Sci
|
2004
|
1.16
|
|
13
|
Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome.
|
J Clin Endocrinol Metab
|
2004
|
1.12
|
|
14
|
Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1.
|
Mamm Genome
|
2004
|
1.10
|
|
15
|
Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
|
Hum Mol Genet
|
2005
|
1.07
|
|
16
|
Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain.
|
Oncogene
|
2003
|
1.06
|
|
17
|
Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.
|
Cancer Res
|
2009
|
1.05
|
|
18
|
The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization.
|
Cancer Res
|
2010
|
0.99
|
|
19
|
The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations.
|
J Clin Endocrinol Metab
|
2007
|
0.98
|
|
20
|
Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.
|
Ann Surg
|
2008
|
0.98
|
|
21
|
Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
|
Surgery
|
2003
|
0.97
|
|
22
|
Persistent primary hyperparathyroidism caused by adenomas identified in pharyngeal or adjacent structures.
|
World J Surg
|
2003
|
0.96
|
|
23
|
Role of preoperative localization and intraoperative localization maneuvers including intraoperative PTH assay determination for patients with persistent or recurrent hyperparathyroidism.
|
J Bone Miner Res
|
2002
|
0.93
|
|
24
|
Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
|
Cancer Res
|
2004
|
0.91
|
|
25
|
Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma.
|
J Clin Endocrinol Metab
|
2004
|
0.90
|
|
26
|
Distribution of menin-occupied regions in chromatin specifies a broad role of menin in transcriptional regulation.
|
Neoplasia
|
2007
|
0.89
|
|
27
|
Utility of rapid intraoperative parathyroid hormone assay to predict severe postoperative hypocalcemia after reoperation for hyperparathyroidism.
|
Surgery
|
2002
|
0.89
|
|
28
|
Parathyroid tumor development involves deregulation of homeobox genes.
|
Endocr Relat Cancer
|
2008
|
0.87
|
|
29
|
Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas.
|
Ann Surg Oncol
|
2005
|
0.87
|
|
30
|
The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism.
|
Surgery
|
2008
|
0.87
|
|
31
|
The MEN1 gene and pituitary tumours.
|
Horm Res
|
2009
|
0.86
|
|
32
|
Mouse embryo fibroblasts lacking the tumor suppressor menin show altered expression of extracellular matrix protein genes.
|
Mol Cancer Res
|
2007
|
0.85
|
|
33
|
Sleeping parathyroid tumor: rapid hyperfunction after removal of the dominant tumor.
|
J Clin Endocrinol Metab
|
2012
|
0.83
|
|
34
|
The parafibromin tumor suppressor protein interacts with actin-binding proteins actinin-2 and actinin-3.
|
Mol Cancer
|
2008
|
0.82
|
|
35
|
Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.
|
J Clin Endocrinol Metab
|
2012
|
0.81
|
|
36
|
Cushing's syndrome in multiple endocrine neoplasia type 1.
|
Clin Endocrinol (Oxf)
|
2012
|
0.81
|
|
37
|
Aggressive pituitary tumors in MEN1: do they refute the two-hit model of tumorigenesis?
|
J Clin Endocrinol Metab
|
2002
|
0.77
|
|
38
|
Mutations in CDKN2C (p18) and CDKN2D (p19) may cause sporadic parathyroid adenoma.
|
Endocr Relat Cancer
|
2013
|
0.77
|
|
39
|
Menin immunoreactivity in secretory granules of human pancreatic islet cells.
|
Appl Immunohistochem Mol Morphol
|
2014
|
0.77
|
|
40
|
Editorial: Imaging to detect early endocrine cancers.
|
J Clin Endocrinol Metab
|
2006
|
0.75
|
|
41
|
Multiple angiofibromas and collagenomas in a 45-year-old man with recurrent nephrolithiasis, fatigue, and vision loss.
|
J Am Acad Dermatol
|
2009
|
0.75
|